Trial Outcomes & Findings for Predictive Value of the FORE-SIGHT™ Monitor for Hemodynamic Deterioration (NCT NCT01706497)

NCT ID: NCT01706497

Last Updated: 2019-05-15

Results Overview

Defined according to the Kidney Disease: Improving Global Outcome criteria (AKI stage 2 or 3) * serum creatinine (SCr) level ≥ 2 times the baseline level, or * urine output (UO) \< 0.5 ml/kg/hour for ≥ 12 hours, or * provision of dialysis

Recruitment status

COMPLETED

Target enrollment

300 participants

Primary outcome timeframe

Predictive window of 6 hours before AKI occurence

Results posted on

2019-05-15

Participant Flow

In this prospective observational cohort study, we had aimed at including 300 patients with continuous NIRS monitoring in place. In only 177 patients we could retrieve a continuous near-infrared spectroscopy monitoring signal of sufficient quality for inclusion in the study.

Participant milestones

Participant milestones
Measure
Post-cardiac Surgery PICU Admissions
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Overall Study
STARTED
177
Overall Study
COMPLETED
177
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Post-cardiac Surgery PICU Admissions
n=177 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Age, Continuous
4 Months
n=177 Participants
Sex: Female, Male
Female
70 Participants
n=177 Participants
Sex: Female, Male
Male
107 Participants
n=177 Participants
Region of Enrollment
Belgium
177 participants
n=177 Participants
Weight
5.2 Kilogram
n=177 Participants
Cyanotic Heart Defect Post Surgery
70 Participants
n=177 Participants
Number of patients on extracorporeal membrane oxygenation (ECMO)
8 Participants
n=177 Participants
CPB duration
84.5 Minutes
n=177 Participants
Delay between PICU admission and NIRS monitoring start
1.1 Minutes
n=177 Participants

PRIMARY outcome

Timeframe: Predictive window of 6 hours before AKI occurence

Population: Of the 177 patients included, 21 patients were excluded: * 4 had AKI within 6 hours after admission * 16 were monitored with NIRS after AKI onset * NIRS monitoring was initiated later than 72 hours in 1 patient, which prevented the fit of prediction time for this patient

Defined according to the Kidney Disease: Improving Global Outcome criteria (AKI stage 2 or 3) * serum creatinine (SCr) level ≥ 2 times the baseline level, or * urine output (UO) \< 0.5 ml/kg/hour for ≥ 12 hours, or * provision of dialysis

Outcome measures

Outcome measures
Measure
Post-cardiac Surgery PICU Admissions
n=156 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
The Accuracy to Predict Acute Kidney Injury (AKI) Per Patient, 6 Hours Before This Clinical Event (AKI) Occurs
55 Participants

SECONDARY outcome

Timeframe: Hospital discharge

participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks

Outcome measures

Outcome measures
Measure
Post-cardiac Surgery PICU Admissions
n=177 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Hospital Length of Stay
10 days
Interval 6.0 to 21.0

SECONDARY outcome

Timeframe: Intensive care unit discharge

participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks

Outcome measures

Outcome measures
Measure
Post-cardiac Surgery PICU Admissions
n=177 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Intensive Care Unit Length of Stay
4 days
Interval 3.0 to 8.0

SECONDARY outcome

Timeframe: ICU discharge

participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks

Outcome measures

Outcome measures
Measure
Post-cardiac Surgery PICU Admissions
n=177 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Duration of Mechanical Ventilation
111.3 hours
Interval 69.3 to 190.4

SECONDARY outcome

Timeframe: Hospital discharge

participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks

Outcome measures

Outcome measures
Measure
Post-cardiac Surgery PICU Admissions
n=177 Participants
Children after cardiac surgery, younger than 12 years old, with an arterial catheter in place, mechanically ventilated upon PICU admission or intubated after admission, and expected to stay at least 24 hours in the PICU, were included in the study.
Hospital Mortality
9 Participants

Adverse Events

Post-cardiac Surgery PICU Admissions

Serious events: 0 serious events
Other events: 0 other events
Deaths: 9 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof Dr Geert Meyfroidt, Associate Professor

University Hospitals Leuven (UZ Leuven) and KU Leuven

Phone: 0032 16 344021

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place